Castle Biosciences Other Current Assets

Castle Biosciences (CSTL) currently reports a other current assets of $15M as of June 2026. That compares with $12M in the prior-year period — up 27.5% year over year. Use the charts on this page to explore Castle Biosciences's other current assets history and peer comparisons.

Castle Biosciences's other current assets increased from $12M to $15M — a 27.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Castle Biosciences reported $15M in other current assets as of June 2026. That compares with $12M in the prior-year period — up 27.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Castle Biosciences, and consider following CSTL for alerts when major investors trade the stock.

Castle Biosciences is classified in the Healthcare sector. On other current assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSTL with unrelated industries.